OBI Pharma has received clearance from the US FDA for an IND application for OBI-902 to begin a Phase I/II trial for advanced ...

Veraxa Biotech has entered a joint discovery partnership with OmniAb tp develop a bispecific antibody drug conjugate (bsADC) ...

The research centered on bacterial conjugation, the process by which bacteria share genetic material, including antibiotic resistance. Hebrew University scientists led by Professors Sigal Ben ...

The GlycOBI conjugation process preserves the antibody structure, ensuring that the ADC maintains biophysical characteristics akin to the native antibody. OBI's linker technology is claimed to ...

Discover how herbal teas like chamomile or rooibos interact with your melanin levels and genetics to influence your skin ...

Narrow-moat Daiichi Sankyo is a Japanese drugmaker with a global footprint and cutting-edge development platform for antibody drug conjugates. As an established pharmaceutical company with a long ...

This helps the bacteria spread resistance genes, even in conditions previously thought to be less favorable for conjugation. "This process of DNA transfer, called bacterial conjugation ...

Students stroll into the classroom on a sunny afternoon. They fall into their assigned seats, open their laptops, and lean in ...